A Novel T-cell Population Expressing the Ectoenzymes CD38 and CD39 is Associated with Melanoma Patient Non-Response to Immunotherapy.

被引：0

作者：

Mitra, Ankita ^{[1
]}

Woods, David M. ^{[2
]}

Rao, Anjali ^{[3
]}

Laino, Andressa S. ^{[4
]}

Winters, Aidan ^{[5
]}

Yanai, Itai ^{[3
]}

Chattopadhyay, Pratip K. ^{[1
]}

Weber, Jeffrey S. ^{[1
]}

机构：

[1] NYU Langone Hlth, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA

[2] Univ Colorado, Sch Med, Div Med Oncol, Dept Med, Aurora, CO USA

[3] NYU, Sch Med, Insitute Computat Med, New York, NY 10003 USA

[4] Moderna Therapeut, Cambridge, MA USA

[5] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

CANCER IMMUNOLOGY RESEARCH | 2021年 / 9卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO030

引用

页数：2

共 50 条

[1] A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
Mitra, Ankita
Thompson, Brian
Strange, Ann
Amato, Carol M.
Vassallo, Melinda
Dolgalev, Igor
Hester-McCullough, Jonathan
Muramatsu, Tomoaki
Kimono, Diana
Puranik, Amrutesh S.
Weber, Jeffrey S.
Woods, David
CLINICAL CANCER RESEARCH, 2023, 29 (20) : 4242 - 4255
[2] The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
Lin, Liyun
Roccuzzo, Gabriele
Yakymiv, Yuliya
Marchisio, Sara
Ortolan, Erika
Funaro, Ada
Senetta, Rebecca
Pala, Valentina
Bagot, Martine
de Masson, Adele
Battistella, Maxime
Guenova, Emmanuella
Ribero, Simone
Quaglino, Pietro
CELLS, 2025, 14 (04)
[3] A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
Horenstein, Alberto L.
Chillemi, Antonella
Zaccarello, Gianluca
Bruzzone, Santina
Quarona, Valeria
Zito, Andrea
Serra, Sara
Malavasi, Fabio
ONCOIMMUNOLOGY, 2013, 2 (09):
[4] CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human Cancer
Kortekaas, Kim E.
Santegoets, Saskia J.
Sturm, Gregor
Ehsan, Ilina
van Egmond, Sylvia L.
Finotello, Francesca
Trajanoski, Zlatko
Welters, Marij J. P.
van Poelgeest, Mariette I. E.
van der Burg, Sjoerd H.
CANCER IMMUNOLOGY RESEARCH, 2020, 8 (10) : 1311 - 1321
[5] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
Mihara, K.
Bhattacharyya, J.
Kitanaka, A.
Yanagihara, K.
Kubo, T.
Takei, Y.
Asaoku, H.
Takihara, Y.
Kimura, A.
LEUKEMIA, 2012, 26 (02) : 365 - 367
[6] T-Cell Immunotherapy with a Chimeric Receptor Against CD38 Is Effective in Eliminating Myeloma Cells
Mihara, Keichiro
Bhattacharyya, Joyeeta
Kitanaka, Akira
Ihara, Akihiro
Sakai, Akira
Kuroda, Yoshiaki
Asaoku, Hideki
Takihara, Yoshihiro
Kimura, Akiro
BLOOD, 2011, 118 (21) : 405 - 405
[7] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
K Mihara
J Bhattacharyya
A Kitanaka
K Yanagihara
T Kubo
Y Takei
H Asaoku
Y Takihara
A Kimura
Leukemia, 2012, 26 : 365 - 367
[8] Targeting CD38 with isatuximab and a novel CD38/CD3xCD28 trispecific T-cell engager in older patients with acute myeloid leukemia
Martin-Sanchez, Esperanza
Blanco, Laura
Kim, Peter S.
Bisht, Kamlesh
Wang, Hongfang
van de Velde, Helgi
Jelinek, Tomas
Simoes, Catia
Prosper, Felipe
Miguel, Jesus F. San
Alfonso, Ana
Bergua, Juan
Rodriguez-Veiga, Rebeca
Vives, Susana
Martinez-Cuadron, David
Montesinos, Pau
Paiva, Bruno
Zabaleta, Aintzane
BLOOD ADVANCES, 2024, 8 (15) : 3875 - 3879
[9] High CD38 expression in childhood T-cell acute lymphoblastic leukemia is not associated with prognosis
Liao, Chan
Shen, Di-Ying
Xu, Xiao-Jun
Song, Hua
Xu, Wei-Qun
Zhao, Fen-Ying
Yang, Shi-Long
Tang, Yong-Min
CANCER BIOMARKERS, 2020, 27 (02) : 277 - 284
[10] T-Cell Immune Imbalance in Rheumatoid Arthritis Is Associated with Alterations in NK Cells and NK-Like T Cells Expressing CD38
Wang, Hongxing
Fang, Kehua
Yan, Weining
Chang, Xiaotian
JOURNAL OF INNATE IMMUNITY, 2021, : 148 - 166

← 1 2 3 4 5 →